{
      "brief_title": [
            "randomize",
            "phase",
            "iii",
            "study",
            "exemestane",
            "aromasin",
            "5",
            "year",
            "versus",
            "tamoxifen",
            "3",
            "year",
            "follow",
            "exemestane"
      ],
      "brief_summary": [
            "compare",
            "effect",
            "exemestane",
            "5",
            "year",
            "versus",
            "tamoxifen",
            "exemestane",
            "give",
            "sequentially",
            "5",
            "year",
            "adjuvant",
            "treatment",
            "postmenopausal",
            "woman",
            "early",
            "breast",
            "cancer",
            "pfizer",
            "sponsor",
            "trial",
            "part",
            "international",
            "collaboration",
            "investigator",
            "conduct",
            "7",
            "similar",
            "yet",
            "independent",
            "study",
            "9",
            "country",
            "study",
            "design",
            "part",
            "larger",
            "team",
            "trial",
            "data",
            "7",
            "study",
            "combine",
            "analysis",
            "pool",
            "data",
            "conduct"
      ],
      "condition": [
            "neoplasm"
      ],
      "intervention_type": [
            "Drug",
            "Drug"
      ],
      "intervention_name": [
            "exemestane (Aromasin)",
            "tamoxifen + exemestane"
      ],
      "description": [
            "orally",
            "25",
            "mg",
            "5",
            "year",
            "20",
            "mg",
            "orally",
            "daily",
            "year",
            "follow",
            "exemestane",
            "orally",
            "25",
            "mg",
            "total",
            "5",
            "year",
            "therapy"
      ],
      "arm_group_label": [
            "exemestane"
      ],
      "other_name": [],
      "criteria": [
            "inclusion",
            "criterion",
            "confirm",
            "adenocarcinoma",
            "breast",
            "follow",
            "adequate",
            "surgical",
            "resection",
            "radiotherapy",
            "adjuvant",
            "chemotherapy",
            "indicate",
            "stage",
            "mo",
            "tnm",
            "stage",
            "bc",
            "adjuvant",
            "hormonal",
            "therapy",
            "consider",
            "exclusion",
            "criterion",
            "patient",
            "deem",
            "potentially",
            "curative",
            "primary",
            "surgical",
            "treatment",
            "one",
            "follow",
            "criterion",
            "inflammatory",
            "breast",
            "cancer",
            "histologically",
            "positive",
            "supraclavicular",
            "nod",
            "local",
            "skin",
            "metastasis",
            "neoadjuvant",
            "chemotherapy",
            "ductal",
            "carcinoma",
            "situ",
            "dci",
            "lobular",
            "carcinoma",
            "situ",
            "lcis",
            "without",
            "invasion",
            "er",
            "pr",
            "negative",
            "primary",
            "tumor",
            "unknown",
            "status"
      ],
      "gender": "Female",
      "minimum_age": [
            "50",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": "No",
      "mesh_term": [
            "neoplasm"
      ],
      "id": "NCT00036270"
}